Percutaneous coronary revascularisation: is it ever worth what it costs?
نویسندگان
چکیده
منابع مشابه
Costs of treatment after renal transplantation: is it worth to pay more?
Objectives: The present study aimed to provide an estimation of the current financial burden of renal transplantation therapy for insurance organisations.Methods: An Excel-based model was developed to determine the treatment costs of current clinical practice in renal transplantation therapy (RTT). Inputs were derived from Ministry of Health and insurance organizations` database, hospital and p...
متن کاملCosts of treatment after renal transplantation: is it worth to pay more?
Objectives: The present study aimed to provide an estimation of the current financial burden of renal transplantation therapy for insurance organisations.Methods: An Excel-based model was developed to determine the treatment costs of current clinical practice in renal transplantation therapy (RTT). Inputs were derived from Ministry of Health and insurance organizations` database, hospital and p...
متن کاملCovering the uninsured: what is it worth?
One out of six Americans under age sixty-five lacks health insurance, a situation that imposes sizable hidden costs upon society. The poorer health and shorter lives of those without coverage account for most of these costs. Other impacts are manifested by Medicare and disability support payments, demands on the public health infrastructure, and losses of local health service capacity. We concl...
متن کاملImaging of parathyroid lesions with radionuclides - Is it worth doing?
Parathyroid adenomas, or hyperplasia may be present in patients with hypercalcemia. Treatment Is by surgical excision, but about 10% of the lesions may be In ectopic locations. Pre-operative localization of the lesions with non-lvasive imaging, using radionuclides, ultrasound, CT, or MR], may simplify surgery, and reduce patient morbidity. However, the reports of the accuracy of the curre...
متن کاملTolerance--is it worth it?
We are entering an exciting time in the study of immunologic tolerance. Several cellular and molecular strategies have been developed that show promise in nonhuman transplant models and these approaches are just now appearing in clinical trials. Tolerance strategies that prevent immune rejection and obviate the need for immunosuppressive medications (with inherent risk of cancer, infection, and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Heart
سال: 2007
ISSN: 1355-6037
DOI: 10.1136/hrt.2007.130401